Thromb Haemost 1998; 80(04): 656-661
DOI: 10.1055/s-0037-1615438
Rapid Communication
Schattauer GmbH

Effects of Three Trans Isomers of Eicosapentaenoic Acid on Rat Platelet Aggregation and Arachidonic Acid Metabolism

C. Loï
1   From the INRA, Unité de Nutrition Lipidique, Dijon
,
J. M. Chardigny
1   From the INRA, Unité de Nutrition Lipidique, Dijon
,
O. Berdeaux
1   From the INRA, Unité de Nutrition Lipidique, Dijon
,
J. M. Vatèle
2   From the ESCIL, Laboratoire de Chimie Organique, Université Claude Bernard Lyon, Villeurbanne
,
D. Poullain
3   From the CEA-Saclay, Service des Molécules Marquées, Gif sur Yvette, France
,
J. P. Noël
3   From the CEA-Saclay, Service des Molécules Marquées, Gif sur Yvette, France
,
J. L. Sébédio
1   From the INRA, Unité de Nutrition Lipidique, Dijon
› Author Affiliations
Further Information

Publication History

Received 05 December 1997

Accepted after resubmission 17 June 1998

Publication Date:
08 December 2017 (online)

Summary

Three trans isomers of eicosapentaenoic acid (EPA) were added to rat platelets stimulated with arachidonic acid (AA) in order to compare their effects on platelet aggregation and on AA oxygenation with those of EPA. The production of metabolites from radiolabelled 20:5Δ17trans was studied also.

EPA induced an inhibition of platelet aggregation of 26.7 ± 6,6 % for a 20:5/20:4 ratio equal to 1. The 20:5Δ11trans and the 20:5Δ11trans,17trans were twice as antiaggregant. In contrast, the 20:5Δ17trans induced similar antiaggregant effect as its cis homologue. Each fatty acid showed a dose-dependent effect. In opposition to EPA, 20:5Δ17trans was also able to induce platelet aggregation (12 ± 4.9% at 5 μM). With regards to the metabolism of AA, 20:5Δ11trans, 20:5Δ17trans and 20:5Δ11trans,17trans (20:5/20:4 = 1) reduced the formation of the cyclooxygenase metabolites (-63%, -37% and -68%, respectively) and enhanced that of 12-HETE (+67%, +38% and +74%, respectively) as compared to EPA.

The analysis showed that radiolabelled 20:5Δ17trans was metabolized into five compounds which remained to be identified. The Rf of three of these compounds (X1, X2 and X4) were those of the metabolites of EPA. Experiments using baicalein induced an inhibition of the production of X2. This suggested that this compound was formed through the 12-lipoxygenase pathway. In the same way, using indomethacin as inhibitor, we observed that X1 and X4 were produced by the cyclooxygenase pathway.

Our results suggest that the trans double bond in the Δ11 position may be responsible of the different physiological effects of the trans polyunsaturated fatty acids as compared to their cis homologue (EPA). Furthermore, 20:5Δ17trans seems to be recognised by the enzymatic system as 20:4 n-6.

 
  • References

  • 1 Ackman RG, Hooper SN. Linolenic acid artifacts from deodorization of oils. J Am Oil Chem Soc 1974; 51: 42-9.
  • 2 Sébédio JL, Grandgirard A, Prevost J. Linoleic acid isomers in heat treated sunflower oils. J Am Oil Chem Soc 1988; 65: 362-6.
  • 3 Grandgirard A, Sébédio JL, Fleury J. Geometrical isomerization of linolenic acid during heat treatment of vegetable oils. J Am Oil Chem Soc 1984; 61: 1563-8.
  • 4 Sébédio JL, Grandgirard A, Septier C, Prevost J. Etat d‘altération de quelques huiles de friture prélevées en restauration. Rev Fr Corps Gras 1987; 1: 15-8.
  • 5 Wolff FL, Sébédio JL. Geometrical isomers of linolenic acid in low-calorie spreads marketed in France. J Am Oil Chem Soc 1991; 68: 719-25.
  • 6 Chardigny JM, Sébédio JL, Berdeaux O. Trans polyunsaturated fatty acids: Occurrence and nutritional implications. In: Adv. in Applied Lipid Res. Volume 2. Padley FB. eds. JAI Press; London: 1996. pp 1-33.
  • 7 O’Keefe SF, Willey V, Gaskins S. Geometrical isomers of essential fatty acids in liquid infant formulas. Food Res Int 1994; 27: 7-13.
  • 8 Chardigny JM, Wolff RL, Mager E, Bayard CC, Sébédio JL, Martine L, Ratnayake WMN. Fatty acid composition of French infant Formulas with emphasis on the content and detailed profile of trans fatty acids. J Am Oil Chem Soc 1996; 73: 1595-601.
  • 9 Ratnayake WMN, Chardigny JM, Wolff RL, Bayard CC, Sébédio JL, Martine L. Essential fatty acids and their trans geometrical isomers in powdered and liquid infant formulas sold in Canada. J Pediatr Gastroenterol Nutr 1997; 25: 400-7.
  • 10 Grandgirard A, Piconneaux A, Sébédio JL, O’Keefe SF, Semon E, Le Quéré JL. Occurrence of geometrical isomers of eicosapentaenoic and docosahexaenoic acids in liver lipids of rats fed heated linseed oil. Lipids 1989; 24: 799-804.
  • 11 Chardigny JM, Sébédio JL, Grandgirard A. Possible physiological effects of trans fatty acids. In: Essential fatty acids and eicosanoids. AOCS. Sinclair A, Gibson R. eds. Champaign; USA: 1993. pp 148-52.
  • 12 Blond JP, Henchiri C, Precigou P, Grandgirard A, Sébédio JL. Effect of 18:3 n-3 geometrical isomers of heated linseed oil on the biosynthesis of arachidonic acid in rat. Nutr Res 1990; 10: 69-79.
  • 13 Chardigny JM, Sébédio JL, Juaneda P, Vatèle JM, Grandgirard A. Occurrence of n-3 trans polyunsaturated fatty acids in human platelets. Nutr Res 1993; 13: 1105-11.
  • 14 O’Keefe SF, Grandgirard A, Sébédio JL. Trans n-3 eicosapentaenoic and docosahexaenoic acid isomers exhibit different inhibitory effects on arachidonic acid metabolism in human platelets compared to the respective cis fatty acids. J Lipid Res 1990; 31: 1241-6.
  • 15 Chardigny JM, Sébédio JL, Juaneda P, Vatèle JM, Grandgirard A. Effects of trans n-3 polyunsaturated fatty acids on human platelet aggregation. Nutr Res 1995; 15: 1463-71.
  • 16 Chardigny JM, Sébédio JL, Grandgirard A, Martine L, Berdeaux O, Vatèle JM. Identification of novel trans isomers of 20:5 n-3 in liver lipids of rats fed heated oil. Lipids 1996; 31: 165-8.
  • 17 Weber PC, Leaf A. Cardiovascular effects of w3 fatty acids. Atherosclerosis risk factor modification by w3fatty acids. Wld Rev Nutr Diet. 1991: 218-32.
  • 18 Eynard T, Poullain D, Vatèle JM, Noël JP, Chardigny JM, Sébédio JL. Synthesis of methyl (5Z,8Z,11Z,14Z,17Z)- and (5Z,8Z,11Z,14Z,17E)-[18-14C] eicosapentaenoate. J Labelled Compd rad 1998; 41: 411-21.
  • 19 Vatèle JM, Dong Doan H, Fenet B, Chardigny JM, Sébédio JL. Synthesis of methyl (5Z,8Z,11E,14Z,17Z)- and (5Z,8Z,11E,14Z,17E)-eicosapentaenoate (EPA Δ11t and EPA Δ11t,17t). Chem Phys Lipids 1995; 78: 65-70.
  • 20 Vatèle JM, Doan HD, Chardigny JM, Sébédio JL, Grandgirard A. Synthesis of methyl (5Z,8Z,11Z,14Z,17E)-eicosapentaenoate and methyl (5Z,7Z,10Z,13Z,16Z,19E)-docosahexaenoate. Chem Phys Lipids 1994; 74: 185-93.
  • 21 Lamothe F, Peyronel D, Sergent M, Iatrides MC, Artaud J, Phan-Tan-Luu R. Saponification of oils rich in polyunsaturated fatty acids : optimization of conditions by response surface methodology. J Am Oil Chem Soc 1988; 65: 652-8.
  • 22 Lagarde M, Bryon PA, Guichardant M, Dechavanne M. A simple and efficient method for platelet isolation from their plasma. Thromb Res 1980; 17: 581-8.
  • 23 Berdeaux O, Chardigny JM, Sébédio JL, Mairot T, Poullain D, Vatèle JM, Noël JP. Effects of a trans isomer of arachidonic acid on rat platelet aggregation and eicosanoid production. J Lipid Res 1996; 37: 2244-50.
  • 24 Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-9.
  • 25 Boukhchache D, Lagarde M. Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim Biophys Acta 1982; 713: 386-92.
  • 26 Willis AL, Kuhn DC. A new potential mediator or arterial thrombosis whose biosynthesis in inhibited by aspirin. Prostaglandins 1973; 4: 127-30.
  • 27 Aharony D, Smith JB, Silver MJ. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid. Biochim Biophys Acta 1982; 718: 193-200.
  • 28 Croset M, Lagarde M. Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem Biophys Res Com 1983; 112: 878-83.
  • 29 Needleman PH, Minkes MS, Raz A. Thromboxane : selective biosynthesis and distinct biological properties. Science 1976; 193: 163-5.
  • 30 Smith WL, Marnett LJ. Prostaglandin endoperoxide synthase : structure and catalysis. Biochim Biophys Acta 1991; 1083: 1-17.
  • 31 Croset M, Lagarde M. Enhancement of eicosenoic acid lipoxygenation in human platelets by 12-hydroperoxy derivative of arachidonic acid. Lipids 1985; 20: 743-50.
  • 32 Hayes KC, Pronczuk A. Sensitivity to platelet aggregation appears related to the lipoprotein profile and atherosclerosis risk in humans and across species. Comp Biochem Physiol 1996; 113B: 349-53.
  • 33 Wolff RL, Combe NA, Entressangles B, Sébédio JL, Grandgirard A. Preferential incorporation of dietary cis-9,cis-12,trans-15 18:3 acid into rat cardiolipins. Biochim Biophys Acta 1993; 1168: 285-91.
  • 34 Sekiya K, Okuda H. Selective inhibition of platelet lipoxygenase by baicalein. Biochem Biophys Res Commun 1982; 105: 1090-5.
  • 35 Salari H, Braquet P, Borgeat P. Comparative effects of indomethacin, acetylenic acids, 15-HETE, nordihydroguaiaretic acid and BW755C on the metabolism of arachidonic acid in human leukocytes and platelets. Prost Leuk Med 1984; 13: 53-60.